Literature DB >> 2692870

Medical approaches to termination of early pregnancy.

P F Van Look, M Bygdeman.   

Abstract

Termination of early pregnancy by vacuum aspiration is a well-established technique. The procedure is highly effective and has a low complication rate, particularly when performed during the first few weeks after missed menses. However, this parasurgical method requires skilled health care personnel, and attempts have therefore been made to find medical alternatives. Prostaglandins were the first agents to be used successfully for this purpose, but the high incidence of mainly gastrointestinal side-effects has limited their widespread use. More recently, attention has focused on antiprogestational steroids, i.e., compounds that prevent the action of progesterone either by inhibiting its biosynthesis or by preventing it from binding to the cellular receptors in target organs. Current experience indicates that these compounds, particularly when used in combination with a low dose of a synthetic prostaglandin analogue, have the potential to become a safe, effective, and acceptable medical method for the termination of early pregnancy.

Entities:  

Keywords:  Abortion, Induced; Biology; Contraception; Contraceptive Methods; Endocrine System; Family Planning; Fertility Control, Postconception; Oral Contraceptives; Oral Contraceptives, Low-dose; Physiology; Prostaglandins; Prostaglandins, Synthetic; Vacuum Aspiration

Mesh:

Substances:

Year:  1989        PMID: 2692870      PMCID: PMC2491296     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  20 in total

1.  Antiprogesterone activity of RU 486 and its contragestive and other applications.

Authors:  E E Baulieu; A Ulmann
Journal:  Hum Reprod       Date:  1986-02       Impact factor: 6.918

2.  Uses of RU 486 for contragestion: an update.

Authors:  A Ulmann
Journal:  Contraception       Date:  1987       Impact factor: 3.375

3.  [Abortion induced by RU 486: importance of its combination with a prostaglandin derivative].

Authors:  C Dubois; A Ulmann; E Aubeny; D Elia; M C Jourdan; M C Van den Bosch; M Leton; E E Baulieu
Journal:  C R Acad Sci III       Date:  1988

4.  Termination of early pregnancy. Future development.

Authors:  M Bygdeman; N J Christensen; K Gréen; S Zheng; V Lundström
Journal:  Acta Obstet Gynecol Scand Suppl       Date:  1983

5.  Progesterone receptor blockage. Effect on uterine contractility and early pregnancy.

Authors:  M Bygdeman; M L Swahn
Journal:  Contraception       Date:  1985-07       Impact factor: 3.375

6.  Early pregnancy termination with antiprogestins: a comparative clinical study of RU 486 given in two dose regimens and Epostane.

Authors:  L Birgerson; V Odlind
Journal:  Fertil Steril       Date:  1987-10       Impact factor: 7.329

7.  Interruption of first trimester human pregnancy following Epostane therapy. Effect of prostaglandin E2 pessaries.

Authors:  M A Webster; S L Phipps; M D Gillmer
Journal:  Br J Obstet Gynaecol       Date:  1985-09

8.  Therapeutic abortion in early pregnancy with antiprogestogen RU486 alone or in combination with prostaglandin analogue (gemeprost).

Authors:  I T Cameron; A F Michie; D T Baird
Journal:  Contraception       Date:  1986-11       Impact factor: 3.375

9.  Termination of very early pregnancy by RU 486--an antiprogestational compound.

Authors:  L Kovacs; M Sas; B A Resch; G Ugocsai; M L Swahn; M Bygdeman; P J Rowe
Journal:  Contraception       Date:  1984-05       Impact factor: 3.375

10.  Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary.

Authors:  M W Rodger; D T Baird
Journal:  Lancet       Date:  1987-12-19       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.